These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 27458229

  • 1. Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal Infection.
    García-de-Lorenzo A, Luque S, Grau S, Agrifoglio A, Cachafeiro L, Herrero E, Asensio MJ, Sánchez SM, Roberts JA.
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5914-21. PubMed ID: 27458229
    [Abstract] [Full Text] [Related]

  • 2. Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis.
    Grau S, Luque S, Campillo N, Samsó E, Rodríguez U, García-Bernedo CA, Salas E, Sharma R, Hope WW, Roberts JA.
    J Antimicrob Chemother; 2015 Oct; 70(10):2854-61. PubMed ID: 26180134
    [Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients.
    Maseda E, Grau S, Luque S, Castillo-Mafla MP, Suárez-de-la-Rica A, Montero-Feijoo A, Salgado P, Gimenez MJ, García-Bernedo CA, Gilsanz F, Roberts JA.
    Crit Care; 2018 Apr 15; 22(1):94. PubMed ID: 29655372
    [Abstract] [Full Text] [Related]

  • 4. Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration.
    Maseda E, Grau S, Villagran MJ, Hernandez-Gancedo C, Lopez-Tofiño A, Roberts JA, Aguilar L, Luque S, Sevillano D, Gimenez MJ, Gilsanz F.
    J Antimicrob Chemother; 2014 Jun 15; 69(6):1624-32. PubMed ID: 24505092
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.
    Boonstra JM, van der Elst KC, Veringa A, Jongedijk EM, Brüggemann RJ, Koster RA, Kampinga GA, Kosterink JG, van der Werf TS, Zijlstra JG, Touw DJ, Alffenaar JWC.
    Antimicrob Agents Chemother; 2017 Dec 15; 61(12):. PubMed ID: 28971861
    [Abstract] [Full Text] [Related]

  • 6. Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients.
    Martial LC, Ter Heine R, Schouten JA, Hunfeld NG, van Leeuwen HJ, Verweij PE, de Lange DW, Pickkers P, Brüggemann RJ.
    Clin Pharmacokinet; 2017 Oct 15; 56(10):1197-1206. PubMed ID: 28144840
    [Abstract] [Full Text] [Related]

  • 7. Micafungin concentrations in the plasma and burn eschar of severely burned patients.
    Sasaki J, Yamanouchi S, Kudo D, Endo T, Nomura R, Takuma K, Kushimoto S, Shinozawa Y, Kishino S, Hori S, Aikawa N.
    Antimicrob Agents Chemother; 2012 Feb 15; 56(2):1113-5. PubMed ID: 22083486
    [Abstract] [Full Text] [Related]

  • 8. Prospective Cohort Study of Micafungin Population Pharmacokinetic Analysis in Plasma and Peritoneal Fluid in Septic Patients with Intra-abdominal Infections.
    Garbez N, Mbatchi L, Wallis SC, Muller L, Lipman J, Roberts JA, Lefrant JY, Roger C.
    Antimicrob Agents Chemother; 2021 Jun 17; 65(7):e0230720. PubMed ID: 33846133
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemia.
    Andes D, Ambrose PG, Hammel JP, Van Wart SA, Iyer V, Reynolds DK, Buell DN, Kovanda LL, Bhavnani SM.
    Antimicrob Agents Chemother; 2011 May 17; 55(5):2113-21. PubMed ID: 21300835
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and Safety of Micafungin in Infants Supported With Extracorporeal Membrane Oxygenation.
    Autmizguine J, Hornik CP, Benjamin DK, Brouwer KL, Hupp SR, Cohen-Wolkowiez M, Watt KM.
    Pediatr Infect Dis J; 2016 Nov 17; 35(11):1204-1210. PubMed ID: 27314826
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic study of anidulafungin in ICU patients with intra-abdominal candidiasis.
    Dupont H, Massias L, Jung B, Ammenouche N, Montravers P.
    J Antimicrob Chemother; 2017 May 01; 72(5):1429-1432. PubMed ID: 28088767
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.
    Mehta PA, Vinks AA, Filipovich A, Bleesing J, Jodele S, Jordan MB, Marsh R, Tarin R, Edwards S, Fearing D, Lawrence J, Davies SM.
    Biol Blood Marrow Transplant; 2010 Oct 01; 16(10):1458-62. PubMed ID: 20546908
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Altered Micafungin Pharmacokinetics in Intensive Care Unit Patients.
    Lempers VJ, Schouten JA, Hunfeld NG, Colbers A, van Leeuwen HJ, Burger DM, Verweij PE, Pickkers P, Brüggemann RJ.
    Antimicrob Agents Chemother; 2015 Aug 01; 59(8):4403-9. PubMed ID: 25963988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.